Search Results - Negar Pourjamal
- Showing 1 - 2 results of 2
-
1
Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan by Negar Pourjamal, Vadim Le Joncour, György Vereb, Cilla Honkamaki, Jorma Isola, Jeffrey V Leyton, Pirjo Laakkonen, Heikki Joensuu, Mark Barok
Published in Translational Oncology (2025-03-01)Get full text
Article -
2
Effectiveness of different de-implementation strategies in primary care: systematic review and meta-analysis by Patrick O Richard, Eddy Lang, Kari A O Tikkinen, Rufus Cartwright, Anton Barchuk, Marco H Blanker, Yoshitaka Aoki, Ilari Kuitunen, Sameer Parpia, Raija Sipilä, Philippe D Violette, Negar Pourjamal, Herney Andrés García-Perdomo, Aleksi Raudasoja, Niko K Nordlund, Alex L E Halme, Jussi M J Mustonen, Robin Vernooij, Petra Falkenbach, Kathryn Crowder, Rachel Gutschon, Tuomas P Kilpeläinen, Tiina Lamberg, Jenifer Matos, Olli P O Nevalainen, Eero Raittio, Jorma T Komulainen
Published in BMJ Medicine (2025-09-01)Get full text
Article
